Kikuo Arakawa

7.5k total citations · 1 hit paper
241 papers, 5.6k citations indexed

About

Kikuo Arakawa is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Kikuo Arakawa has authored 241 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Cardiology and Cardiovascular Medicine, 53 papers in Endocrinology, Diabetes and Metabolism and 52 papers in Molecular Biology. Recurrent topics in Kikuo Arakawa's work include Lipoproteins and Cardiovascular Health (31 papers), Blood Pressure and Hypertension Studies (26 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (26 papers). Kikuo Arakawa is often cited by papers focused on Lipoproteins and Cardiovascular Health (31 papers), Blood Pressure and Hypertension Studies (26 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (26 papers). Kikuo Arakawa collaborates with scholars based in Japan, United States and Germany. Kikuo Arakawa's co-authors include Hidenori Urata, Munehito Ideishi, Koichiro Kumagai, Keijiro Saku, Naoki Gondo, Junichi Sasaki, Hideko Nakashima, Manabu Sasaguri, Akio Kinoshita and Hiroshige Itakura and has published in prestigious journals such as Nature, The Lancet and Journal of the American Chemical Society.

In The Last Decade

Kikuo Arakawa

230 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial

2006 686 citations Kikuo Arakawa et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kikuo Arakawa Japan	36	2.9k	1.4k	1.3k	929	500	241	5.6k
James M. Ritter United Kingdom	43	3.3k 1.1×	1.0k 0.7×	816 0.6×	1.1k 1.1×	1.5k 3.0×	121	6.5k
Peter M. Schofield United Kingdom	35	2.1k 0.7×	1.9k 1.3×	437 0.3×	1.6k 1.7×	655 1.3×	114	6.9k
Gilles R. Dagenais Canada	32	2.4k 0.8×	1.6k 1.1×	2.0k 1.5×	453 0.5×	608 1.2×	107	5.3k
H. Sinzinger Austria	36	1.1k 0.4×	1.3k 0.9×	660 0.5×	798 0.9×	672 1.3×	421	5.2k
Jean‐Claude Tardif Canada	38	2.5k 0.9×	1.9k 1.3×	695 0.5×	698 0.8×	298 0.6×	107	4.8k
Pasquale Perrone Filardi Italy	47	4.8k 1.7×	2.1k 1.5×	1.4k 1.1×	687 0.7×	540 1.1×	311	7.9k
Claudio Ceconi Italy	46	3.1k 1.1×	710 0.5×	483 0.4×	1.7k 1.8×	966 1.9×	180	6.7k
R. Paoletti Italy	36	2.0k 0.7×	1.8k 1.2×	846 0.7×	1.4k 1.5×	689 1.4×	182	5.8k
R Peto United Kingdom	8	2.3k 0.8×	4.4k 3.1×	2.0k 1.6×	454 0.5×	497 1.0×	19	7.5k
Shui‐Ping Zhao China	35	1.2k 0.4×	1.5k 1.1×	1.0k 0.8×	1.0k 1.1×	534 1.1×	235	4.3k

Countries citing papers authored by Kikuo Arakawa

Since Specialization

Citations

This map shows the geographic impact of Kikuo Arakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kikuo Arakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kikuo Arakawa more than expected).

Fields of papers citing papers by Kikuo Arakawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kikuo Arakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kikuo Arakawa. The network helps show where Kikuo Arakawa may publish in the future.

Co-authorship network of co-authors of Kikuo Arakawa

This figure shows the co-authorship network connecting the top 25 collaborators of Kikuo Arakawa. A scholar is included among the top collaborators of Kikuo Arakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kikuo Arakawa. Kikuo Arakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim‐Mitsuyama, Shokei, Hisao Ogawa, Kunihiko Matsui, et al.. (2012). An angiotensin II receptor blocker–calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone. Kidney International. 83(1). 167–176. 28 indexed citations

Matsushita, Yasuyuki, et al.. (2004). Relation of Serum Total Cholesterol and Other Factors to Risk of Cerebral Infarction in Japanese Men With Hypercholesterolemia : The Kyushu Lipid Intervention Study. Japanese Circulation Journal-english Edition. 69(1). 1–6. 1 indexed citations

Yui, Yoshiki, Tetsuya Sumiyoshi, Kazuhisa Kodama, et al.. (2002). Long-term Effects of Nifedipine Retard vs ACE Inhibitors in Hypertension with Coronary Artery Disease : Final Reports of J-MIC(B). Japanese Circulation Journal-english Edition. 66. 357. 1 indexed citations

Arakawa, Kikuo, Keishi Abe, Takao Saruta, et al.. (2002). The long-term safety of BIBR277 (Telmisartan), the long-acting angiotensin II AT1 receptor antagonist, in patients with mild-to-moderate essential hypertension. 30. 103–119. 1 indexed citations

Arakawa, Kikuo. (2000). Physical exercise in the management of hypertension. 43(3). 107–113. 5 indexed citations

Saku, Keijiro, Bo Zhang, Takao Ohta, & Kikuo Arakawa. (1999). Quantity and function of high density lipoprotein as an indicator of coronary atherosclerosis. Journal of the American College of Cardiology. 33(2). 436–443. 43 indexed citations

Takeda, Seiji, et al.. (1996). Relation between Nutrition of Patients and Methicillin-resistant Staphylococcus aureus (MRSA). Kansenshogaku zasshi. 70(4). 354–359. 1 indexed citations

Sakai, Takaaki, Hirokazu Maeda, Naomichi Matsumoto, et al.. (1995). Plasma Free and Sulfoconjugated Dopamine before and after a Half-Marathon. Hypertension Research. 18(SupplementI). S161–S163. 4 indexed citations

Liu, Rui, Shiro Jimi, Keitaro Matsuo, et al.. (1995). Combined Effects of Pravastatin and Probucol on High-Density Lipoprotein Apolipoprotein A-I Kinetics in Cholesterol-fed Rabbits.. Japanese Circulation Journal. 59(5). 292–298. 2 indexed citations

10.

Tsuchiya, Yoshihiro, et al.. (1994). Coronary collateral circulation and diastolic function. International Journal of Cardiology. 44(1). 37–44. 3 indexed citations

11.

Zanchetti, Alberto, John Chalmers, Kikuo Arakawa, et al.. (1993). 1993 Guidelines for the management of mild hypertension: MEMORANDUM from a World Health Organization/International Society of Hypertension meeting. Journal of Hypertension. 11(9). 905–918. 203 indexed citations

12.

Mori, Tsukasa, Koichi Handa, Hiroaki Tanaka, et al.. (1992). Effects of arotinolol on exercise capacity and humoral factors during exercise in normal subjects. Cardiovascular Drugs and Therapy. 6(4). 387–390. 2 indexed citations

13.

Matsunaga, Akira, et al.. (1991). Effect of simvastatin on receptor mediated metabolism of low density lipoprotein in guinea pigs. Atherosclerosis. 90(1). 31–37. 16 indexed citations

14.

Hong, Ying, Keijiro Saku, Ryoko Harada, et al.. (1990). Putative mechanisms of action of probucol on high-density lipoprotein apolipoprotein A-I and its isoproteins kinetics in rabbits. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1047(3). 247–254. 16 indexed citations

15.

Tanabe, Yoichi, Hidenori Urata, Akira Kiyonaga, et al.. (1989). Changes in Serum Concentrations of Taurine and Other Amino Acids in Clinical Antihypertensive Exercise Therapy. Clinical and Experimental Hypertension Part A Theory and Practice. 11(1). 149–165. 40 indexed citations

16.

Sasaki, Junichi, et al.. (1988). Elevated levels of HDL2-cholesterol and apo A-I in national class Japanese male marathon runners. Atherosclerosis. 70(1-2). 175–177. 10 indexed citations

17.

Hiroki, Tadayuki, et al.. (1988). New electrocardiographic criteria for diagnosing right ventricular hypertrophy in mitral stenosis. Comparison with Bonner's and Mortara's criteria.. Japanese Circulation Journal. 52(10). 1114–1120. 7 indexed citations

18.

Ogihara, Toshio, Masao Ikeda, Yuichiro Goto, et al.. (1987). The Effect of Low Dose Carvedilol on Circadian Variation of Blood Pressure in Patients with Essential Hypertension. Journal of Cardiovascular Pharmacology. 10. S108–S112. 13 indexed citations

19.

Arakawa, Kikuo, et al.. (1985). Change of taste by ear acupuncture in simple obese patients.. Zen Nihon Shinkyu Gakkai zasshi (Journal of the Japan Society of Acupuncture and Moxibustion). 34(3/4). 211–216. 1 indexed citations

20.

Arakawa, Kikuo, et al.. (1984). Comparison between cardia point and lung point on auricular acupuncture.. Zen Nihon Shinkyu Gakkai zasshi (Journal of the Japan Society of Acupuncture and Moxibustion). 33(3). 279–284. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact